Form 8-K - Current report:
SEC Accession No. 0001104659-25-054876
Filing Date
2025-05-30
Accepted
2025-05-30 16:07:42
Documents
17
Period of Report
2025-05-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516583d2_8k.htm   iXBRL 8-K 33059
2 EXHIBIT 1.1 tm2516583d2_ex1-1.htm EX-1.1 217191
3 EXHIBIT 5.1 tm2516583d2_ex5-1.htm EX-5.1 10322
7 GRAPHIC tm2516583d2_ex5-1img001.jpg GRAPHIC 25430
8 GRAPHIC tm2516583d2_ex5-1img002.jpg GRAPHIC 1021
9 GRAPHIC tm2516583d2_ex5-1img003.jpg GRAPHIC 1355
  Complete submission text file 0001104659-25-054876.txt   523082

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rsls-20250530.xsd EX-101.SCH 3047
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20250530_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20250530_pre.xml EX-101.PRE 22380
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2516583d2_8k_htm.xml XML 3572
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 251010919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)